Lyby K[au] - Search Results

Year	Number of Results
1986	1
1992	2
1998	1
2000	1
2005	1
2007	1
2011	1
2019	2
2021	1
2024	0

1

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.

Nishimura E, Pridal L, Glendorf T, Hansen BF, Hubálek F, Kjeldsen T, Kristensen NR, Lützen A, Lyby K, Madsen P, Pedersen TÅ, Ribel-Madsen R, Stidsen CE, Haahr H. Nishimura E, et al. Among authors: lyby k. BMJ Open Diabetes Res Care. 2021 Aug;9(1):e002301. doi: 10.1136/bmjdrc-2021-002301. BMJ Open Diabetes Res Care. 2021. PMID: 34413118 Free PMC article. Clinical Trial.

2

The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects.

Halberg IB, Lyby K, Wassermann K, Heise T, Plum-Mörschel L, Zijlstra E. Halberg IB, et al. Among authors: lyby k. Clin Pharmacokinet. 2019 Nov;58(11):1497-1504. doi: 10.1007/s40262-019-00772-2. Clin Pharmacokinet. 2019. PMID: 31093929 Free PMC article. Clinical Trial.

3

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.

Halberg IB, Lyby K, Wassermann K, Heise T, Zijlstra E, Plum-Mörschel L. Halberg IB, et al. Among authors: lyby k. Lancet Diabetes Endocrinol. 2019 Mar;7(3):179-188. doi: 10.1016/S2213-8587(18)30372-3. Epub 2019 Jan 21. Lancet Diabetes Endocrinol. 2019. PMID: 30679095 Clinical Trial.

4

Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.

Birkeland KI, Home PD, Wendisch U, Ratner RE, Johansen T, Endahl LA, Lyby K, Jendle JH, Roberts AP, DeVries JH, Meneghini LF. Birkeland KI, et al. Among authors: lyby k. Diabetes Care. 2011 Mar;34(3):661-5. doi: 10.2337/dc10-1925. Epub 2011 Jan 26. Diabetes Care. 2011. PMID: 21270174 Free PMC article. Clinical Trial.

5

Impact of follicular-fluid meiosis-activating sterol in an albumin-based formulation on the incidence of human pre-embryos with chromosome abnormalities.

Loft A, Ziebe S, Erb K, Rasmussen PE, Agerholm I, Hauge B, Bungum M, Bungum L, Grøndahl C, Lyby K. Loft A, et al. Among authors: lyby k. Fertil Steril. 2005 Oct;84 Suppl 2:1269-76. doi: 10.1016/j.fertnstert.2005.05.017. Fertil Steril. 2005. PMID: 16210020 Free article. Clinical Trial.

6

Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression.

Montgomery SA, Rasmussen JG, Lyby K, Connor P, Tanghøj P. Montgomery SA, et al. Among authors: lyby k. Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:65-70. doi: 10.1097/00004850-199206005-00007. Int Clin Psychopharmacol. 1992. PMID: 1431024 Clinical Trial. No abstract available.

7

Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes.

Smitz J, Picton HM, Platteau P, Rutherford A, Cortvrindt R, Clyde J, Nogueira D, Devroey P, Lyby K, Gröndahl C. Smitz J, et al. Among authors: lyby k. Fertil Steril. 2007 Apr;87(4):949-64. doi: 10.1016/j.fertnstert.2006.10.009. Epub 2007 Jan 2. Fertil Steril. 2007. PMID: 17198705 Free article. Clinical Trial.

8

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.

Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M, Refsum HE, Ofsti E, Eriksson S, Syversen S. Nyth AL, et al. Among authors: lyby k. Acta Psychiatr Scand. 1992 Aug;86(2):138-45. doi: 10.1111/j.1600-0447.1992.tb03242.x. Acta Psychiatr Scand. 1992. PMID: 1529737 Clinical Trial.

9

Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study.

Uldall P, Bulteau C, Pedersen SA, Dulac O, Lyby K. Uldall P, et al. Among authors: lyby k. Epilepsy Res. 2000 Dec;42(2-3):159-68. doi: 10.1016/s0920-1211(00)00173-x. Epilepsy Res. 2000. PMID: 11074188

10

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.

Kälviäinen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K. Kälviäinen R, et al. Among authors: lyby k. Epilepsy Res. 1998 Mar;30(1):31-40. doi: 10.1016/s0920-1211(97)00082-x. Epilepsy Res. 1998. PMID: 9551842 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year